In this free webinar, learn ways to optimize dry eye disease clinical trial designs and execution for future treatments currently in the pipeline. Attendees will learn about dry eye disease trial composition, endpoint selection and methods and models that together reduce data variability and increase the likelihood of program success. The featured speakers will discuss techniques and protocol approaches to improve endpoint sensitivity, reduce screen failure rates and increase harmonization across sites.
TORONTO, Nov. 15, 2023 /PRNewswire-PRWeb/ -- Discover a groundbreaking webinar delving into the future of dry eye clinical trial design and execution for emerging treatments. A highly prevalent multi-factorial disease affecting millions of patients, dry eye disease can still be a challenging condition to treat today. While recent advancements offer additional tools and novel mechanisms of action for clinicians, there are still significant treatment gaps requiring innovation.
The challenge, however, is that these new treatments under development often require a different approach to clinical trials compared to their predecessors. From the need to prove the impact on both clinical signs and patient symptoms, to reducing the impact of influential environmental or lifestyle facets, how researchers approach clinical trial design can make or break program success.
In this webinar, featured speakers George W. Ousler III, Ora Senior Vice President of Anterior Segment, and Dr. Ethan Bensinger, PhD, Visual Psychophysics Specialist and Ora Director of R&D New Technology, will discuss ways to optimize dry eye clinical trial designs and execution. During this talk, attendees will hear about techniques and protocol approaches to improve endpoint sensitivity, reduce screen failure rates and increase harmonization across sites. The discussion will also include insights on trial designs, endpoint selection, recruitment and methods to reduce data variability.
Ora, Inc. is the only ophthalmic clinical trials company with a research and development (R&D) department focused on the evolution of clinical trials. Join this webinar for an engaging discussion on how important lessons learned from Ora's over 30 years of experience are being leveraged to design and conduct the dry eye clinical studies of the future.
Join George W. Ousler III, Senior Vice President, Anterior Segment, Ora; and Dr. Ethan Bensinger, PhD, Visual Psychophysics Specialist, Ora Director of R&D New Technology, for the live webinar on Monday, December 4, 2023, at 1pm EST (10am PST).
For more information, or to register for this event, visit Unlocking Dry Eye Innovation with The Latest Clinical Designs and Technologies.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article